Colonoscopies, a widely used method for preventing colorectal cancer in America, are being questioned for their efficacy based on the results of a recent comprehensive trial. Despite being the primary method of screening in the U.S., the study’s results, showing modest reductions in colorectal cancer incidence and mortality, have generated debate among gastroenterologists.
Key Points:
- Colorectal cancer is the second-most deadly cancer, causing over 1 million deaths annually worldwide. In the U.S., colonoscopies have been the go-to method for prevention.
- A new large-scale trial, the Nordic-European Initiative on Colorectal Cancer (NordICC), aimed to measure the efficacy of colonoscopies in reducing colorectal cancer and related deaths.
- The trial’s results indicated an 18% reduction in colorectal cancer incidence, but only a 10% reduction in mortality from the disease—results that many found surprising.
- The results sparked debate, with some suggesting colonoscopies are not cost-effective, while others defended their benefits.
- Alternatives to colonoscopies, like occult blood tests and sigmoidoscopies, have been shown to reduce colorectal cancer mortality by varying percentages.
Source: https://asteriskmag.com/issues/04/you-re-invited-to-a-colonoscopy
